If you made any changes in Pure, your changes will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 10 Similar Profiles
HIV Medicine & Life Sciences
Mortality Medicine & Life Sciences
Coronary Disease Medicine & Life Sciences
CD4 Lymphocyte Count Medicine & Life Sciences
Blood Pressure Medicine & Life Sciences
HIV Infections Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Cardiovascular Diseases Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1999 2024

PALM

Neaton, J.

Leidos Biomedical Research, Inc.

11/21/1811/18/19

Project: Research project

HIV Biomarker Testing

Neaton, J.

Leidos Biomedical Research, Inc.

4/9/1812/31/19

Project: Research project

Biomarkers
HIV
Ebola Hemorrhagic Fever
Viral RNA
Humoral Immunity
Mortality

Research Output 1973 2019

2 Citations (Scopus)

A longitudinal study of Ebola sequelae in Liberia

PREVAIL III Study Group, Mar 7 2019, In : New England Journal of Medicine. 380, 10, p. 924-934 11 p.

Research output: Contribution to journalArticle

Liberia
Longitudinal Studies
Survivors
Uveitis
Ebolavirus
2 Citations (Scopus)

Association of rivaroxaban with thromboembolic events in patients with heart failure, coronary disease, and sinus rhythm: A post hoc analysis of the commander hf trial

Greenberg, B., Neaton, J., Anker, S. D., Byra, W. M., Cleland, J. G. F., Deng, H., Fu, M., La Police, D. A., Lam, C. S. P., Mehra, M. R., Nessel, C. C., Spiro, T. E., Van Veldhuisen, D. J., Vanden Boom, C. M. & Zannad, F., Jan 1 2019, In : JAMA cardiology.

Research output: Contribution to journalArticle

Coronary Sinus
Coronary Disease
Heart Failure
Sudden Death
Coronary Artery Disease
1 Citation (Scopus)

Clinical development of therapeutic agents for hospitalized patients with influenza: Challenges and innovations

King, J. C., Beigel, J. H., Ison, M. G., Rothman, R. E., Uyeki, T. M., Walker, R. E., Neaton, J., Tegeris, J. S., Zhou, J. A., Armstrong, K. L., Carter, W., Miele, P. S., Willis, M. S., Dugas, A. F., Tracy, L. R. A., Vock, D. M. & Bright, R. A., Apr 1 2019, In : Open Forum Infectious Diseases. 6, 4

Research output: Contribution to journalArticle

Open Access
Proxy
Human Influenza
Triage
Therapeutics
Hospital Emergency Service
Open Access
Human Influenza
Hospitalization
Intravenous Immunoglobulins
Health Status
Placebos

Determination of fasiglifam-induced liver toxicity: Insights from the data monitoring committee of the fasiglifam clinical trials program

Shavadia, J. S., Sharma, A., Gu, X., Neaton, J., DeLeve, L., Holmes, D., Home, P., Eckel, R. H., Watkins, P. B. & Granger, C. B., Jan 1 2019, In : Clinical Trials.

Research output: Contribution to journalArticle

Clinical Trials Data Monitoring Committees
Aspartate Aminotransferases
Alanine Transaminase
Liver
Chemical and Drug Induced Liver Injury